Journal article · 1998

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients

Gerhard Behre, Hartmut Link, Georg Maschmeyer, Peter Meyer, U. Paaz, Martin Wilhelm, Wolfgang Hiddemann

Annals of Hematology, 76(2), 73–80 · Published 12 March 1998 · DOI 10.1007/s002770050366

View at the publisherCite this paper

In brief

“Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients” is a 1998 journal article by Gerhard Behre and 6 co-authors, published in Annals of Hematology. OpenAlex counts 54 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
54
Most cited in
2012 (2)
Field-weighted impact
1.48
References
37
Authors
7

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Behre, G., Link, H., Maschmeyer, G., Meyer, P., Paaz, U., Wilhelm, M., & Hiddemann, W. (1998). Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients. Annals of Hematology, 76(2), 73–80. https://doi.org/10.1007/s002770050366

MLA 9

Behre, Gerhard, et al. “Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.” Annals of Hematology, vol. 76, no. 2, 1998, pp. 73–80. https://doi.org/10.1007/s002770050366.

Chicago

Behre, Gerhard, Hartmut Link, Georg Maschmeyer, Peter Meyer, U. Paaz, Martin Wilhelm, and Wolfgang Hiddemann. 1998. “Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.” Annals of Hematology 76 (2): 73–80. https://doi.org/10.1007/s002770050366.

Harvard

Behre, G. et al. (1998) ‘Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients’, Annals of Hematology, 76(2), pp. 73–80. doi:10.1007/s002770050366.

IEEE

G. Behre et al., “Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients,” Annals of Hematology, vol. 76, no. 2, pp. 73–80, 1998, doi: 10.1007/s002770050366.

BibTeX

@article{behre1998meropenem,
  title     = {{Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients}},
  author    = {Behre, Gerhard and Link, Hartmut and Maschmeyer, Georg and Meyer, Peter and Paaz, U. and Wilhelm, Martin and Hiddemann, Wolfgang},
  journal   = {Annals of Hematology},
  year      = {1998},
  volume    = {76},
  number    = {2},
  pages     = {73--80},
  doi       = {10.1007/s002770050366},
  url       = {https://doi.org/10.1007/s002770050366}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201222
201322
201422
201522
202011
202122
202311
202411

Its field-weighted citation impact is 1.48: it has been cited 1.48 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • meropenem
  • ceftazidime
  • amikacin
  • febrile neutropenia
  • empirical antibiotic therapy
  • combination antibiotic therapy
  • hematologic malignancies
  • solid tumors

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Behre, G., Link, H., Maschmeyer, G., Meyer, P., Paaz, U., Wilhelm, M., & Hiddemann, W. (1998). Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients. Annals of Hematology, 76(2), 73–80. https://doi.org/10.1007/s002770050366

How many times has this paper been cited?

54 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Gerhard Behre, Hartmut Link, Georg Maschmeyer, Peter Meyer, U. Paaz, Martin Wilhelm, Wolfgang Hiddemann.

What is the DOI of this paper?

10.1007/s002770050366, permanently at https://doi.org/10.1007/s002770050366. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.